NASDAQ:ASPX - Auspex Pharmaceuticals Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$100.96Today's RangeN/A52-Week Range$14.75 - $101.00VolumeN/AAverage Volume1.02 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people with movement disorders and other rare diseases, including orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea (abnormal involuntary movements) associated with Huntington's disease, an orphan disease, tardive dyskinesia and Tourette syndrome in the pediatric population, which is an orphan disease, as well as other orphan indications. Its lead product candidate is SD-809, which is a small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its other programs include SD-560, SD-1077 and SD-254. Receive ASPX News and Ratings via Email Sign-up to receive the latest news and ratings for ASPX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:ASPX Previous Symbol CUSIPN/A WebN/A Phone+1-858-5582400 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$0.00 OptionableNot Optionable Auspex Pharmaceuticals (NASDAQ:ASPX) Frequently Asked Questions What is Auspex Pharmaceuticals' stock symbol? Auspex Pharmaceuticals trades on the NASDAQ under the ticker symbol "ASPX." How were Auspex Pharmaceuticals' earnings last quarter? Auspex Pharmaceuticals Inc (NASDAQ:ASPX) issued its earnings results on Monday, March, 16th. The biopharmaceutical company reported ($0.74) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.59) by $0.15. View Auspex Pharmaceuticals' Earnings History. Has Auspex Pharmaceuticals been receiving favorable news coverage? Media stories about ASPX stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Auspex Pharmaceuticals earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news articles about the biopharmaceutical company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. How do I buy shares of Auspex Pharmaceuticals? Shares of ASPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. How can I contact Auspex Pharmaceuticals? Auspex Pharmaceuticals' mailing address is 3333 N Torrey Pines Ct Ste 400, LA JOLLA, CA 92037-1023, United States. The biopharmaceutical company can be reached via phone at +1-858-5582400. MarketBeat Community Rating for Auspex Pharmaceuticals (NASDAQ ASPX)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 119 (Vote Outperform)Underperform Votes: 99 (Vote Underperform)Total Votes: 218MarketBeat's community ratings are surveys of what our community members think about Auspex Pharmaceuticals and other stocks. Vote "Outperform" if you believe ASPX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ASPX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/10/2018 by MarketBeat.com StaffFeatured Article: What is Compound Interest?